MEDIFAST Financial Statements From 2010 to 2025

MED Stock  USD 14.35  0.41  2.94%   
MEDIFAST INC financial statements provide useful quarterly and yearly information to potential MEDIFAST INC investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MEDIFAST INC financial statements helps investors assess MEDIFAST INC's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MEDIFAST INC's valuation are summarized below:
Gross Profit
444.6 M
Profit Margin
0.0035
Market Capitalization
152.5 M
Enterprise Value Revenue
0.0104
Revenue
602.5 M
There are over one hundred nineteen available fundamental ratios for MEDIFAST INC, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of MEDIFAST INC's last-minute performance against the performance from 2010 to 2025 to make sure the company is sustainable in the future. The current year's Market Cap is expected to grow to about 465.9 M. The current year's Enterprise Value is expected to grow to about 417.1 M

MEDIFAST INC Total Revenue

367.53 Million

Check MEDIFAST INC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEDIFAST INC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.8 M, Interest Expense of 5 M or Selling General Administrative of 235.3 M, as well as many indicators such as Price To Sales Ratio of 0.3, Dividend Yield of 0.0035 or PTB Ratio of 0.87. MEDIFAST financial statements analysis is a perfect complement when working with MEDIFAST INC Valuation or Volatility modules.
  
Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

MEDIFAST INC Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets298.4 M284.2 M195.5 M
Slightly volatile
Short and Long Term Debt Total16.9 M16.1 M11.3 M
Slightly volatile
Other Current Liabilities18.1 M33.1 M28.5 M
Slightly volatile
Total Current Liabilities36.9 M64.2 M59.2 M
Slightly volatile
Total Stockholder Equity220.6 M210.1 M125.2 M
Slightly volatile
Property Plant And Equipment Net28 M48.7 M38.8 M
Slightly volatile
Cash95.5 M90.9 M67.5 M
Slightly volatile
Non Current Assets Total73.3 M69.8 M47.1 M
Slightly volatile
Cash And Short Term Investments50.9 M90.9 M82.2 M
Slightly volatile
Common Stock Total Equity12.3 K12.7 K12 K
Very volatile
Common Stock Shares Outstanding12.2 M11 M11.8 M
Very volatile
Liabilities And Stockholders Equity298.4 M284.2 M195.5 M
Slightly volatile
Non Current Liabilities Total7.1 M9.9 M9.1 M
Slightly volatile
Inventory28.4 M42.4 M43.4 M
Slightly volatile
Other Current Assets85.1 M81.1 M18.5 M
Slightly volatile
Total Liabilities43.9 M74.1 M68.2 M
Slightly volatile
Property Plant And Equipment Gross112.4 M107 M55.2 M
Slightly volatile
Total Current Assets225.1 M214.4 M148.4 M
Slightly volatile
Common Stock12.2 K12.7 K12 K
Very volatile
Accounts Payable21.5 M23.1 M31.3 M
Slightly volatile
Other Assets21.5 M20.5 M7.2 M
Slightly volatile
Property Plant Equipment69.1 M65.8 M37.5 M
Slightly volatile
Net Tangible Assets125 M178.3 M118.4 M
Slightly volatile
Retained Earnings Total Equity126.9 M160.8 M117 M
Slightly volatile
Other Liabilities177.8 K187.2 K1.3 M
Slightly volatile
Short and Long Term Debt277.2 K197.1 K301 K
Slightly volatile
Non Current Liabilities Other246.2 K259.2 K1.1 M
Slightly volatile
Cash And Equivalents100.8 M100.8 M77.8 M
Slightly volatile
Net Invested Capital171.7 M210.1 M136.3 M
Slightly volatile
Net Working Capital119.9 M150.2 M100.5 M
Slightly volatile
Capital Stock9.3 K9.9 K11.6 K
Slightly volatile
Deferred Long Term Asset Charges2.4 M2.7 M2.9 M
Slightly volatile

MEDIFAST INC Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization15.8 M15.1 M9.1 M
Slightly volatile
Selling General Administrative235.3 M441.7 M369.3 M
Slightly volatile
Total Revenue367.5 M602.5 M592.4 M
Slightly volatile
Gross Profit270.6 M444.6 M436.6 M
Slightly volatile
Other Operating Expenses326.4 M599.6 M525.2 M
Slightly volatile
Operating Income2.7 M2.9 M64.8 M
Slightly volatile
EBIT152.6 M145.4 M82.8 M
Slightly volatile
EBITDA2.7 M2.9 M71.7 M
Slightly volatile
Cost Of Revenue96.9 M157.8 M155.8 M
Slightly volatile
Total Operating Expenses229.5 M441.7 M369.3 M
Slightly volatile
Income Before Tax3.6 M3.8 M65.6 M
Slightly volatile
Net IncomeM2.1 M49.1 M
Slightly volatile
Net Income Applicable To Common Shares173.4 M165.1 M72.7 M
Slightly volatile
Net Income From Continuing OpsM2.1 M55.7 M
Slightly volatile
Selling And Marketing Expenses2.9 M3.1 M10.9 M
Slightly volatile
Tax Provision1.6 M1.7 M16.9 M
Slightly volatile
Interest IncomeM4.8 M1.3 M
Slightly volatile
Reconciled Depreciation8.8 M12.7 M6.4 M
Slightly volatile

MEDIFAST INC Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow99.2 M94.4 M63.1 M
Slightly volatile
Depreciation12.5 M11.9 MM
Slightly volatile
Capital Expenditures7.3 M7.5 M9.2 M
Pretty Stable
Net IncomeM2.1 M49.5 M
Slightly volatile
End Period Cash Flow95.5 M90.9 M67.5 M
Slightly volatile
Stock Based Compensation4.8 M7.4 MM
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.30.31971.3568
Very volatile
Dividend Yield0.00350.00370.0268
Pretty Stable
PTB Ratio0.870.91666.3138
Pretty Stable
Days Sales Outstanding0.250.263.093
Slightly volatile
Book Value Per Share20.1819.223110.7339
Slightly volatile
Stock Based Compensation To Revenue0.01160.01220.0094
Very volatile
Capex To Depreciation0.590.6261.1955
Pretty Stable
PB Ratio0.870.91666.3138
Pretty Stable
EV To Sales0.190.19551.2602
Pretty Stable
ROIC0.00670.0070.3227
Slightly volatile
Inventory Turnover2.663.72083.8796
Pretty Stable
Net Income Per Share0.180.19134.2011
Slightly volatile
Days Of Inventory On Hand93.1998.097297.9601
Very volatile
Payables Turnover4.946.84746.2985
Slightly volatile
Sales General And Administrative To Revenue0.480.540.5879
Slightly volatile
Research And Ddevelopement To Revenue0.00490.00490.0045
Slightly volatile
Capex To Revenue0.01180.01240.0175
Slightly volatile
Cash Per Share15.614.85318.0568
Slightly volatile
Interest Coverage249237284
Slightly volatile
Days Payables Outstanding70.8253.304762.0121
Slightly volatile
ROE0.00950.010.3573
Slightly volatile
PE Ratio87.592.102629.2713
Slightly volatile
Return On Tangible Assets0.0070.00740.2147
Slightly volatile
Earnings Yield0.01140.01090.0544
Very volatile
Intangibles To Total Assets0.00360.00380.0067
Slightly volatile
Current Ratio2.333.34172.7084
Slightly volatile
Tangible Book Value Per Share20.1819.223110.7189
Slightly volatile
Receivables Turnover1.5 K1.4 K760
Slightly volatile
Graham Number14.589.096428.2645
Slightly volatile
Shareholders Equity Per Share20.1819.223110.7339
Slightly volatile
Debt To Equity0.08060.07670.1079
Pretty Stable
Capex Per Share0.440.6820.7493
Pretty Stable
Revenue Per Share57.8855.120152.3461
Slightly volatile
Interest Debt Per Share1.551.47530.8918
Slightly volatile
Debt To Assets0.05390.05670.0597
Pretty Stable
Enterprise Value Over EBITDA42.9740.925515.1507
Slightly volatile
Price Earnings Ratio87.592.102629.2713
Slightly volatile
Operating Cycle93.1998.0972101
Pretty Stable
Price Book Value Ratio0.870.91666.3138
Pretty Stable
Days Of Payables Outstanding70.8253.304762.0121
Slightly volatile
Pretax Profit Margin0.0060.00630.0954
Very volatile
Ebt Per Ebit0.751.31580.9888
Pretty Stable
Operating Profit Margin0.00450.00480.0945
Very volatile
Company Equity Multiplier1.061.35271.5482
Very volatile
Long Term Debt To Capitalization0.04940.0520.0584
Very volatile
Total Debt To Capitalization0.06770.07130.0884
Very volatile
Return On Capital Employed0.01240.01310.4414
Slightly volatile
Debt Equity Ratio0.08060.07670.1079
Pretty Stable
Ebit Per Revenue0.00450.00480.0945
Very volatile
Quick Ratio1.562.68051.9976
Pretty Stable
Net Income Per E B T0.580.55220.7311
Slightly volatile
Cash Ratio1.491.41721.2074
Pretty Stable
Cash Conversion Cycle42.5544.792548.9172
Pretty Stable
Days Of Inventory Outstanding93.1998.097297.9601
Very volatile
Days Of Sales Outstanding0.250.263.093
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.920.69550.912
Pretty Stable
Price To Book Ratio0.870.91666.3138
Pretty Stable
Fixed Asset Turnover7.6212.375513.8956
Slightly volatile
Enterprise Value Multiple42.9740.925515.1507
Slightly volatile
Debt Ratio0.05390.05670.0597
Pretty Stable
Price Sales Ratio0.30.31971.3568
Very volatile
Return On Assets0.0070.00740.2144
Slightly volatile
Asset Turnover1.792.11982.8172
Slightly volatile
Net Profit Margin0.00330.00350.0686
Very volatile
Gross Profit Margin0.540.7380.7115
Very volatile
Price Fair Value0.870.91666.3138
Pretty Stable
Return On Equity0.00950.010.3573
Slightly volatile

MEDIFAST INC Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap465.9 M443.7 M410.4 M
Slightly volatile
Enterprise Value417.1 M397.2 M369.7 M
Slightly volatile

MEDIFAST Fundamental Market Drivers

Cash And Short Term Investments90.9 M

MEDIFAST Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MEDIFAST INC Financial Statements

MEDIFAST INC stakeholders use historical fundamental indicators, such as MEDIFAST INC's revenue or net income, to determine how well the company is positioned to perform in the future. Although MEDIFAST INC investors may analyze each financial statement separately, they are all interrelated. For example, changes in MEDIFAST INC's assets and liabilities are reflected in the revenues and expenses on MEDIFAST INC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in MEDIFAST INC. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue316 K300.2 K
Total Revenue602.5 M367.5 M
Cost Of Revenue157.8 M96.9 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.54  0.48 
Capex To Revenue 0.01  0.01 
Revenue Per Share 55.12  57.88 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.87)
Earnings Share
0.19
Revenue Per Share
55.12
Quarterly Revenue Growth
(0.38)
Return On Assets
0.0324
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.